330 related articles for article (PubMed ID: 36740671)
1. FYN: emerging biological roles and potential therapeutic targets in cancer.
Peng S; Fu Y
J Transl Med; 2023 Feb; 21(1):84. PubMed ID: 36740671
[TBL] [Abstract][Full Text] [Related]
2. Fyn is induced by Ras/PI3K/Akt signaling and is required for enhanced invasion/migration.
Yadav V; Denning MF
Mol Carcinog; 2011 May; 50(5):346-52. PubMed ID: 21480388
[TBL] [Abstract][Full Text] [Related]
3. FYNagling divergent adhesive functions for Fyn in keratinocytes.
Fenton SE; Denning MF
Exp Dermatol; 2015 Feb; 24(2):81-5. PubMed ID: 24980626
[TBL] [Abstract][Full Text] [Related]
4. microRNA-125a-3p reduces cell proliferation and migration by targeting Fyn.
Ninio-Many L; Grossman H; Shomron N; Chuderland D; Shalgi R
J Cell Sci; 2013 Jul; 126(Pt 13):2867-76. PubMed ID: 23606749
[TBL] [Abstract][Full Text] [Related]
5. Fyn: a novel molecular target in cancer.
Saito YD; Jensen AR; Salgia R; Posadas EM
Cancer; 2010 Apr; 116(7):1629-37. PubMed ID: 20151426
[TBL] [Abstract][Full Text] [Related]
6. The inhibition of SRC family kinase suppresses pancreatic cancer cell proliferation, migration, and invasion.
Je DW; O YM; Ji YG; Cho Y; Lee DH
Pancreas; 2014 Jul; 43(5):768-76. PubMed ID: 24763074
[TBL] [Abstract][Full Text] [Related]
7. Fyn and SRC are effectors of oncogenic epidermal growth factor receptor signaling in glioblastoma patients.
Lu KV; Zhu S; Cvrljevic A; Huang TT; Sarkaria S; Ahkavan D; Dang J; Dinca EB; Plaisier SB; Oderberg I; Lee Y; Chen Z; Caldwell JS; Xie Y; Loo JA; Seligson D; Chakravari A; Lee FY; Weinmann R; Cloughesy TF; Nelson SF; Bergers G; Graeber T; Furnari FB; James CD; Cavenee WK; Johns TG; Mischel PS
Cancer Res; 2009 Sep; 69(17):6889-98. PubMed ID: 19690143
[TBL] [Abstract][Full Text] [Related]
8. Src family kinases are required for integrin but not PDGFR signal transduction.
Klinghoffer RA; Sachsenmaier C; Cooper JA; Soriano P
EMBO J; 1999 May; 18(9):2459-71. PubMed ID: 10228160
[TBL] [Abstract][Full Text] [Related]
9. Srcasm corrects Fyn-induced epidermal hyperplasia by kinase down-regulation.
Li W; Marshall C; Mei L; Gelfand J; Seykora JT
J Biol Chem; 2007 Jan; 282(2):1161-9. PubMed ID: 17046829
[TBL] [Abstract][Full Text] [Related]
10. FYN promotes breast cancer progression through epithelial-mesenchymal transition.
Xie YG; Yu Y; Hou LK; Wang X; Zhang B; Cao XC
Oncol Rep; 2016 Aug; 36(2):1000-6. PubMed ID: 27349276
[TBL] [Abstract][Full Text] [Related]
11. Fyn is an important molecule in cancer pathogenesis and drug resistance.
Elias D; Ditzel HJ
Pharmacol Res; 2015 Oct; 100():250-4. PubMed ID: 26305432
[TBL] [Abstract][Full Text] [Related]
12. FYN expression potentiates FLT3-ITD induced STAT5 signaling in acute myeloid leukemia.
Chougule RA; Kazi JU; Rönnstrand L
Oncotarget; 2016 Mar; 7(9):9964-74. PubMed ID: 26848862
[TBL] [Abstract][Full Text] [Related]
13. Deficiency of Fyn protein is prerequisite for apoptosis induced by Src family kinase inhibitors in human mesothelioma cells.
Eguchi R; Kubo S; Takeda H; Ohta T; Tabata C; Ogawa H; Nakano T; Fujimori Y
Carcinogenesis; 2012 May; 33(5):969-75. PubMed ID: 22354875
[TBL] [Abstract][Full Text] [Related]
14. Distinct roles for N-Cadherin linked c-Src and fyn kinases in lens development.
Leonard M; Zhang L; Bleaken BM; Menko AS
Dev Dyn; 2013 May; 242(5):469-84. PubMed ID: 23361870
[TBL] [Abstract][Full Text] [Related]
15. Differential transformation capacity of Src family kinases during the initiation of prostate cancer.
Cai H; Smith DA; Memarzadeh S; Lowell CA; Cooper JA; Witte ON
Proc Natl Acad Sci U S A; 2011 Apr; 108(16):6579-84. PubMed ID: 21464326
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of Tyrosine Kinase FYN in Human Thyroid Carcinoma: Role in Modulating Tumor Cell Proliferation, Invasion, and Migration.
Zheng J; Li H; Xu D; Zhu H
Cancer Biother Radiopharm; 2017 Nov; 32(9):320-326. PubMed ID: 29140740
[TBL] [Abstract][Full Text] [Related]
17. Identification and activation of Src family kinases in primary megakaryocytes.
Lannutti BJ; Shim MH; Blake N; Reems JA; Drachman JG
Exp Hematol; 2003 Dec; 31(12):1268-74. PubMed ID: 14662334
[TBL] [Abstract][Full Text] [Related]
18. Role of Fyn in hematological malignancies.
Li S; Liu C; Tang Y
J Cancer Res Clin Oncol; 2023 Aug; 149(9):6759-6767. PubMed ID: 36754870
[TBL] [Abstract][Full Text] [Related]
19. Src kinases as therapeutic targets for cancer.
Kim LC; Song L; Haura EB
Nat Rev Clin Oncol; 2009 Oct; 6(10):587-95. PubMed ID: 19787002
[TBL] [Abstract][Full Text] [Related]
20. SRC family kinase FYN promotes the neuroendocrine phenotype and visceral metastasis in advanced prostate cancer.
Gururajan M; Cavassani KA; Sievert M; Duan P; Lichterman J; Huang JM; Smith B; You S; Nandana S; Chu GC; Mink S; Josson S; Liu C; Morello M; Jones LW; Kim J; Freeman MR; Bhowmick N; Zhau HE; Chung LW; Posadas EM
Oncotarget; 2015 Dec; 6(42):44072-83. PubMed ID: 26624980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]